• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[서울경제] [주목!바이오벤처-큐로셀] “고형암도 치료 가능한 CAR-T…연내 임상 시작”

2020/09/23

[주목!바이오벤처-큐로셀] ‘고형암도 치료 가능한 CAR-T…연내 임상 시작’ | 서울경제 (sedaily.com)

서울경제 우영탁 기자

Prev국내 CAR-T 개발을 선도하는 큐로셀, 차별화된 기술력과 역량을 바탕으로 시리즈C 440억원 투자유치
Next[이데일리] 단1회 투입으로 2개월만 말기암 완치 ‘기적의 신약’
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.